Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of COVID‐19 in Liver Disease Progression
Miguel Ángel Martı́nez, Sandra Franco
Hepatology Communications (2021) Vol. 5, Iss. 7, pp. 1138-1150
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Long‐term side effects and lingering symptoms post COVID‐19 recovery
Mohammad Zarei, Deepanwita Bose, Masoud Nouri‐Vaskeh, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 3
Open Access | Times Cited: 68
Uneven metabolic and lipidomic profiles in recovered COVID‐19 patients as investigated by plasma NMR metabolomics
Maider Bizkarguenaga, Chiara Bruzzone, Rubén Gil‐Redondo, et al.
NMR in Biomedicine (2021) Vol. 35, Iss. 2
Open Access | Times Cited: 42
Outcomes of COVID-19 among patients with liver disease
Isidora S Vujcic
World Journal of Gastroenterology (2023) Vol. 29, Iss. 5, pp. 815-824
Open Access | Times Cited: 18
COVID-19 and Its Effects on the Hepatobiliary System: A Literature Review
Sariya Khan, Jumana Hussain Timraz, Nourah A. Al Ghamdi, et al.
Cureus (2025)
Open Access
COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications
Mohammad Tarique Imam, Ziyad S. Almalki, Abdullah R. Alzahrani, et al.
International Immunopharmacology (2023) Vol. 121, pp. 110439-110439
Open Access | Times Cited: 9
Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19
Olivier Deckmyn, Thierry Poynard, Pierre Bédossa, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 699-699
Open Access | Times Cited: 15
Genome‐scale metabolic modelling of SARS‐CoV‐2 in cancer cells reveals an increased shift to glycolytic energy production
Elisabeth Yaneske, Guido Zampieri, Loris Bertoldi, et al.
FEBS Letters (2021) Vol. 595, Iss. 18, pp. 2350-2365
Open Access | Times Cited: 18
Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease
Mohammad Sadiq Jeeyavudeen, Rahul Chaudhari, Joseph M. Pappachan, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 3, pp. 487-502
Open Access | Times Cited: 6
A nationwide study of liver disease hospitalizations during the coronavirus pandemic in the United States
Mary Sedarous, Michael Youssef, Ayooluwatomiwa D. Adekunle, et al.
Journal of Gastroenterology and Hepatology (2023) Vol. 38, Iss. 7, pp. 1148-1157
Closed Access | Times Cited: 6
Effect of SARS-CoV-2 infection on the liver
Adekunle Sanyaolu, Aleksandra Marinković, Abu Fahad Abbasi, et al.
World Journal of Virology (2023) Vol. 12, Iss. 2, pp. 109-121
Open Access | Times Cited: 6
Insight into the liver dysfunction in COVID-19 patients: Molecular mechanisms and possible therapeutic strategies
Naina Khullar, Jasvinder Singh Bhatti, Satwinder Singh, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 14, pp. 2064-2077
Open Access | Times Cited: 5
COVID-19, Possible Hepatic Pathways and Alcohol Abuse—What Do We Know up to 2023?
Agata Michalak, Tomasz Lach, Karolina Szczygieł, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2212-2212
Open Access | Times Cited: 1
The histologic and molecular correlates of liver disease in fatal COVID-19 including with alcohol use disorder
Gerard J. Nuovo, David Suster, Hamdy Awad, et al.
Annals of Diagnostic Pathology (2021) Vol. 57, pp. 151881-151881
Open Access | Times Cited: 12
Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions—Review of the Literature
Săndica Bucurică, Florentina Ioniţă‐Radu, Ana Bucurica, et al.
Medicina (2022) Vol. 59, Iss. 1, pp. 62-62
Open Access | Times Cited: 8
Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2
Alef Aragão Carneiro dos Santos, Luiz Eduardo Rodrigues, Amanda Lins Alecrim-Zeza, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 7
Systems biology approach reveals a common molecular basis for COVID-19 and non-alcoholic fatty liver disease (NAFLD)
Shitao Jiang, Yao-Ge Liu, Lei Zhang, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 7
Liver function in transgender persons: Challenges in the COVID-19 era
Charalampos Milionis, Ιoannis Ilias, Eftychia Koukkou
World Journal of Clinical Cases (2023) Vol. 11, Iss. 2, pp. 299-307
Open Access | Times Cited: 3
A case-control autopsy series of liver pathology associated with novel coronavirus disease (COVID-19)
Fabiola A. Righi, Richard S. Vander Heide, Rondell P. Graham, et al.
Annals of Diagnostic Pathology (2023) Vol. 68, pp. 152240-152240
Closed Access | Times Cited: 3
Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions
Priyanka Saha, Subhankar Bose, Amit Kumar Srivastava, et al.
Molecules (2021) Vol. 26, Iss. 22, pp. 6783-6783
Open Access | Times Cited: 7
Endogenous Carboxyhemoglobin Level Variation in COVID-19 and Bacterial Sepsis: A Novel Approach?
Bianca-Liana Grigorescu, Irina Săplăcan, Ioana Roxana Bordea, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 305-305
Open Access | Times Cited: 5
Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study
Arunkumar Krishnan, Ruhee A Patel, Yousaf Hadi, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 1, pp. 68-78
Open Access | Times Cited: 2
Gastrointestinal and Liver Manifestations in Children with COVID-19 and Their Relationship to Clinical Course
Gülsüm Alkan, Melike Emiroğlu, Şadiye Kübra Tüter Öz, et al.
Turkish Archives of Pediatrics (2022) Vol. 57, Iss. 4, pp. 413-420
Open Access | Times Cited: 4
A systems biology approach for investigating significantly expressed genes among COVID-19, hepatocellular carcinoma, and chronic hepatitis B
Babak Sokouti
Egyptian Journal of Medical Human Genetics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 4
The impact of the COVID-19 pandemic on non-COVID-associated mortality: A descriptive longitudinal study of UK data
S. O. Makanjuola, Saran Shantikumar
Public Health in Practice (2024) Vol. 7, pp. 100489-100489
Open Access
Overview: Global burden of liver disease
Krushna Baviskar, Aniket Kshirsagar, Hemant Raut, et al.
International Journal of Pharmaceutical Chemistry and Analysis (2024) Vol. 11, Iss. 1, pp. 1-10
Open Access
Page 1 - Next Page

Scroll to top